Bleeding Disorder Completed Phase 4 Trials for Fibrinogen human (DB09222)

IndicationStatusPhase
DBCOND0042114 (Bleeding Disorder)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02864875Early Administration of Fibrinogen in Polytraumatized Patients With Hypofibrinogenemia: a Randomized Feasibility TrialTreatment